期刊文献+

他汀类降脂药能降低缺血性脑卒中患者再发卒中的风险 被引量:8

Effects of statins on second prevention of ischemic stroke and transient ischemic attack
原文传递
导出
摘要 目的观察他汀类药物在缺血性脑卒中二级预防中的作用。方法将2006年以来在本院住院治疗的脑卒中/TIA患者60例随机分为他汀干预组和对照组。对照组仅接受康复治疗及危险因素治疗,干预组在对照组治疗基础上加用阿托伐他汀20mg1次/d治疗,观察3年内两组患者再发脑卒中/TIA,死亡以及其他心血管事件发生率。结果干预组再发脑卒中/TIA,冠脉事件发生率低于对照组,而死亡率,脑出血发生率两组却无明显差异。结论他汀类药物能有效预防脑卒中/TIA患者再发心脑血管事件的发生。 Objective To observe the effects of statins on second prevention of isehemic stroke and transient isehemic attack. Methods 60 cases with ischemic stroke or transient ischemic attack which were collected from March 2006 to January 2007 were divided into control group and statins-treating group randomly. The control group only received routine treating containing rehabilitation care and risk factors controlling. The statins-treating group received atorvastatin 20 mg qd except routine treating. The incidence of ischemie stroke/ transient isehemic attack recurrence, death,other heart-cerebral vessel events were collected within 3 years. Resuits The incidence of ischemie stroke/transient isehemic attack recurrence, coronary artery events in statinstreating group was lower significantly than in the control group, and no significantly deference was found in the incidence of death and encephalorrhagia between two groups. Conclusion Statins can reduce incidence of ischemic/transient ischemic attack recurrence, coronary artery events.
作者 张韩英
出处 《中国临床实用医学》 2010年第4期64-65,共2页 China Clinical Practical Medicine
关键词 脑卒中/TIA 他汀类药物 二级预防 Ischemic stroke/ransient ischemic attack Statins Second prevention
  • 相关文献

参考文献8

  • 1他汀类药物预防缺血性卒中/短暂性脑缺血发作专家组.他汀类药物预防缺血性卒中/TIA专家建议[J].中国卒中杂志,2007,2(4):340-343. 被引量:15
  • 2Larry B Goldstein, Robert Adams, Mark J Alberts, et al. Primary prevention of ischemic stroke : a guideline from the American heart association/American stroke association stroke council. Stroke, 2006,37 : 1583-1633.
  • 3Wolf PA, Kannel WB, Verter J. Current status of risk factors for stroke. Neurol Clin,1983,1:317-343.
  • 4Zhang X, Patel A, Horibe H,et al. Asia pacific cohort studies collaboration cholesterol, coronary artery disease, and stroke in the asia pacific region. Int J Epidemiol,2003 ,32 :563-572.
  • 5Bots ML, Elwood PC, Nikitin Y, et al. Total and HDL cholesterol and risk of stroke. EUROSIROKE : a collaborative study among research centres in Europe. J Epidemiol Community Health, 2002, 56 : 19-i24.
  • 6Cholesterol Treatment Trialist' (CTT) Collaborators. Effects and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet, 2005,366 : 1267 -1278.
  • 7O' Regan C,Wu P,Aroa P,et al. Statin therapy in stroke prevention: a meta-analysis involving 121 000 patients. The American journal of medicine ,2008,121:24-33.
  • 8Amarenco P, Goldstein LB, Szarek Michael, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (sparcl) trial. Stroke,2007,38 : 3198 - 3204.

二级参考文献14

  • 1[4]Cannon Co,strinberg BA,Murphy SA,et al.Metaanalysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy[J].J Am Coll Cardiol,2006,48:438-445.
  • 2[5]Amarenco P,Bogousslavsky J,Callahan A,et al.High-dose atorvastatin after stroke or transient ischemic attack[J].N Engl J Med,2006,355:549-559.
  • 3[6]Guyton JR.Bogousslavsky J,Callahan A,et al.Highdose atorvastatin after stroke or transient ischemic attack[J].N Engl J Med,2006,355:549-559.
  • 4[7]Gotto AM Jr.Statins,cardiovascular disease,and drug safety[J].Am J Cardiol,2006,97(8A):95C-97C.
  • 5[8]Thompson PD,Clarkson PM,Rosenson RS,et al.An assessment of statin safety by muscle sxperts[J].Am J Cardiol,2006,97(8A):69C-76C.
  • 6[9]Coben DE,Anania FA,Chalasani N,et al.An assessment of statin safety by muscle sxperts[J].Am J Cardiol,2006,97(8A):77C-81C.
  • 7[10]LaRosa JC,Grundy SM,Waters DD,et al.Intensive lipid lowering with atorvastatin in patients with stable coronary disease[J].N Engl J Med,2005,352:1425-1435.
  • 8[11]Goldstein LB,Adams R,Alberts MJ,et al.Primary prevention of ischemic stroke:a guideline from the American Heart Association/American Stroke Association Stroke Council:cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council;Nutrition,Physical Activity,and Metabolism Council; and the Quality of the American Academy of Neurology affirms the balue of this guideline[J].Stroke,2006,37:1583-1633.
  • 9[12]Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲguidelines[J].Circulation,2004,110:227-239.
  • 10[13]Schwartz GG,Olsson AG,Ezekowitz MD,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial[J].JAMA,2001,285:1711-1718.

共引文献14

同被引文献126

引证文献8

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部